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Abstract
Stress during pregnancy is associated with metabolic dysfunction in the adult
offspring in human and other animals. However, little is known about the
metabolic effects of pregnancy stress on the mothers and fetuses during preg-
nancy itself. This study aimed to determine the consequences of the common
experimental procedures of injection and single housing in pregnant rats on
fetal and maternal hepatic glucogenic capacities. On day (D) 20 of pregnancy,
feto-placental weights and the glycogen content and activities of phospho-
enolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) of
fetal and maternal liver were measured in rats pair or single housed from D1
with or without saline injection from D15 to D19. Housing and saline injec-
tion both affected hepatic glucogenic capacity. In maternal liver, saline injec-
tion but not housing reduced glycogen content and raised G6Pase activity,
whereas housing but not treatment increased PEPCK activity. In fetuses, hous-
ing and injection interacted in regulating PEPCK activity and reducing hepatic
glycogen content and placental weight. Body weight was decreased and hepatic
G6Pase increased by injection but not housing in the fetuses. Single-housed
dams ate less than those pair-housed near term while saline injection elevated
maternal plasma corticosterone concentrations. Thus, single housing and sal-
ine injection are both stresses during rat pregnancy that alter feto-placental
weight and hepatic glucogenic capacity of the fetuses and dams near term.
Routine experimental procedures per se may, therefore, have consequences for
offspring hepatic phenotype as well as modifying the outcomes of dietary and
other environmental challenges during pregnancy.
Introduction
Human epidemiological studies have shown that stress
during pregnancy is often associated with low birth
weight and an increased risk of adult-onset and other dis-
eases, such as glucose intolerance, Type 2 diabetes,
asthma, hypertension, and behavioral disorders (Barker
1994; Martin-Gronert and Ozanne 2012; Hanson and
Gluckman 2014; Mina and Reynolds 2014; Vaiserman
2015; Andersson et al. 2016). In experimental animals,
intrauterine programming of adult glucoregulatory mech-
anisms has been demonstrated in a number of species
using a range of techniques to induce maternal stress dur-
ing pregnancy (Reusens and Remacle 2001; McMillen and
Robinson 2005; Martin-Gronert and Ozanne 2012; Mina
and Reynolds 2014). In rats, maternal restraint, dietary
manipulation, and direct glucocorticoid administration
have all been shown to cause postnatal abnormalities in
hepatic glucose metabolism in the offspring consistent
with the human epidemiological data (McMillen and
Robinson 2005; Martin-Gronert and Ozanne 2012; Mina
and Reynolds 2014). In particular, rats exposed in utero
to these stresses are glucose intolerant with increased hep-
atic gluconeogenic enzyme activities and abnormal
responses to glucoregulatory hormones as adults (Burns
et al. 1997; Desai et al. 1997; Nyirenda et al. 1998; Lesage
et al. 2004; D’Mello and Liu 2006; Franko et al. 2010).
Increased hepatic gluconeogenic enzyme activities are also
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seen in rat fetuses when growth is restricted by maternal
protein deprivation, indicating that the postnatal abnor-
malities may arise in utero (Franko et al. 2009).
Experimental procedures, such as individual housing,
handling, and saline injection, frequently used as controls
in developmental studies, can be stressful and cause
changes in food intake and raised corticosterone concen-
trations in pregnant and nonpregnant rats (Ward and
Weisz 1984; Barbazanges et al. 1996). Glucocorticoids and
undernutrition are known to alter hepatic glycogen con-
tent and enhance gluconeogeneic enzyme activities in
nonpregnant adult animals (Weber and Cantero 1957;
Perez et al. 1964; Oh et al. 1970; Franko et al. 2007).
However, the extent to which routine experimental proce-
dures cause stress during pregnancy and impairs fetal-pla-
cental development and enhances hepatic glucogenic
capacity of the mother and fetus remains largely
unknown. This study, therefore, tested the hypothesis that
two common experimental procedures, single housing
and saline injection, would alter feto-placental growth and
hepatic glucogenic capacity of rat dams and their fetuses
near term. Hepatic glycogen content and activities of the
key rate-limiting glucogenic enzymes, phophoenolpyru-
vate caboxykinase (PEPCK) and glucose-6-phosphate
(G6Pase), were measured in fetal and maternal liver from
rats housed individually with or without saline injection
near term and compared to similarly treated dams more
naturally housed in pairs.
Materials and Methods
Animals
Twenty-nine virgin female Wistar rats aged 12–15 weeks
were used (Charles Rivers, Saffron Walden UK). They
were maintained at 22°C on a 12 h light/dark cycle and
fed a standard laboratory chow throughout (Standard
Breeding Diet No 3, Special Diet Services, Essex, UK).
Females were mated overnight with a male Wistar rat.
The presence of a copulatory plug was taken as day (D) 0
of pregnancy (term is D21.5). All dams were weighed on
D0 and D20. Food intake was measured for each cage
and calculated as gram per rat per day. All studies were
carried out under the Animal (Scientific Procedures) Act
1986 of the UK Government after ethical approval of the
Animal Welfare and Ethical Review Board of the Univer-
sity of Cambridge.
Experimental procedures
Before mating, all females were group housed, whereas,
afterward, they were housed either individually (n = 13)
or in pairs (n = 16 rats; eight pairs) in identical cages.
Between 08.00 and 09.00 h on D15 to D19 inclusive,
seven single-housed and eight pair-housed dams (both
animals from four cages) were injected subcutaneously
with saline (0.9% w/v NaCl, 200 lL/100 g body
weight). Between 08.00 and 10.00 h on D20, all dams
were anesthetized with a mixture of sodium pentobarbi-
tone and chloral hydrate (Equithesin, 0.6 mL/100 g
body weight, ip). Once anesthetized, a 2 mL blood
sample was collected from the uterine vein for mea-
surement of blood glucose and plasma corticosterone
concentrations. Fetuses and placentas were removed
individually and weighed. Fetuses were killed by decapi-
tation and their glucose concentration measured in
blood from the severed neck vessels. The fetal liver was
removed, weighed, and frozen in liquid nitrogen for
subsequent analyses of glycogen content and gluco-
neogenic enzyme activities. The fetuses were sexed visu-
ally after removal of the liver. After delivery of the
entire litter, the dam was killed with a lethal dose of
anesthetic (200 mg/kg sodium pentobarbitone, Dolthetal,
Ventoquinol, UK Ltd). Maternal liver was collected and
frozen in liquid nitrogen. Maternal blood samples were
centrifuged at 4°C and the plasma stored at 20°C.
One of the pair-housed, saline injected dams had an
abnormally small litter (five pups) so this animal was
excluded from any further analyses. Food intake for
this cage was also discounted. The numbers of dams in
each group was, therefore, as follows: pair housed and
untreated (UT) n = 8 dams, pair housed and saline
injected (INJ) n = 7 dams, single housed and untreated
n = 6 dams, and, finally, single housed and saline
injected n = 7 dams.
Biochemical analyses
Blood glucose concentrations were measured using a
hand-held glucometer (Lifespan, Ortho-Clinical Diagnos-
tics, High Wycombe, UK). The hepatic glycogen content
and activities of G6Pase (EC 3.1.3.9) and PEPCK (EC
4.1.1.49) were measured in all dams and one male and
one female fetus per litter per variable (chosen ran-
domly) using established methods described in detail
previously (Fowden et al. 1993; Franko et al. 2007,
2009). The interassay coefficients of variation of a fetal
homogenate in the glycogen, G6Pase, and PEPCK assays
were 9%, 11.8%, and 5%, respectively. Hepatic protein
content was determined using a Lowry assay. Plasma
corticosterone concentrations were measured by radioim-
munoassay using a single kit (ImmuChem, Orangeburg,
NY). The lower limit of sensitivity of the assay was
10 ng/mL and the intraassay coefficient of variation was
<10%. All biochemical and hormone analyses were made
in duplicate.
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Statistical analyses
Mean (SE) values have been used throughout. Maternal
data were analyzed by two-way ANOVA with housing
and treatment as factors using the Holm–Sidak post hoc
test for all subsequent pair-wise comparisons. Initially,
fetal data were analyzed by three-way ANOVA with hous-
ing, treatment, and sex of the fetus as factors. This
showed no effect of sex, or any interaction between sex
and the other two factors, in determining any of morpho-
metric or biochemical variables measured. Consequently,
for fetal data, statistical analyses used litter means irre-
spective of sex for comparisons between groups using
two-way ANOVA as for the maternal data. For fetal mor-
phometric and glucose data, the whole litter was averaged
while, for the hepatic variables, values for the two fetuses
assayed per litter were averaged. Correlation between vari-
ables was assessed by Pearson’s correlation analyses. Sta-
tistical significance was accepted when P < 0.05 (Sigma
Stat 3.5, Systat Software, Point Richmond, CA).
Results
Morphometry and biochemical composition
Maternal body weight was similar in all four groups on
D0 (Table 1). However, by D20, maternal body weight
was greater in dams housed in pairs than singly (Table 1).
Maternal weight gain between D0 and D20 was influenced
by both housing and injection with smaller weight gains
in dams housed singly than in pairs and in those saline-
injected relative to untreated dams (Table 1). Maternal
food intake was similar in all four groups until D15 but,
thereafter, singly housed dams ate less than those pair
housed, irrespective of whether the animals were injected
or not (Table 1). Litter size did not differ between groups
(Table 1). Housing and injection interacted in determin-
ing maternal hepatic protein content with significantly
lower values in singly housed, saline-injected dams than
in their untreated or pair-housed counterparts (Table 1).
Maternal corticosterone concentrations were significantly
higher in saline-injected than uninjected dams, irrespec-
tive of housing (Table 1). There were no significant dif-
ferences in maternal or fetal blood glucose concentrations
between groups (Table 1 & 2).
On D20, placental weight was influenced significantly
by injection and by interactions between injection and
housing (Table 2). Placental weight was higher in unin-
jected than saline-injected dams due primarily to an effect
in pair-housed animals (Table 2). Placental weight in
uninjected dams was lower in singly than pair-housed
dams (Table 2). Fetal weight was also affected by injec-
tion with lower weights in injected than uninjected dams
(Table 2). There was no significant interaction between
housing and injection in determining fetal weight
(Table 2). Fetal liver weight was influenced significantly
by housing but not by treatment, whether expressed as
absolute weight or as a percentage of body weight
(Table 2). Fetal hepatic protein content did not differ
between groups (Table 2).
Glucogenic capacity
At D20, maternal hepatic glycogen content per gram wet
weight was significantly lower in saline-injected than
uninjected dams, irrespective of housing (Fig. 1A). Hous-
ing had no significant effect on maternal hepatic glycogen
content and there was no interaction between housing
and injection (Fig. 1A). In the fetuses, both housing and
injection were significant influences on hepatic glycogen
content whether expressed per gram wet weight of liver,
per gram wet weight of fetus, or as total content (Fig. 2A,
Table 2). There was also a significant interaction between
these two factors in determining fetal hepatic glycogen
content, irrespective of how values were expressed
(Fig. 2A). Glycogen content per gram fetal liver was lower
in injected than uninjected dams that were pair housed
but not in those singly housed (Fig. 2A, Table 2). It was
also lower in fetuses of untreated dams singly housed rel-
ative to their pair-housed counterparts (Fig. 2A, Table 2).
Maternal hepatic G6Pase activity, whether expressed
per gram protein or per gram wet weight of liver, was
influenced significantly by injection with higher activities
in saline-injected than untreated dams, irrespective of
housing (Fig. 1B, Table 1). In contrast, maternal hepatic
PEPCK activity was unaffected by injection but was influ-
enced by housing with significantly higher activities in
singly than pair-housed dams (Figure 1C, Table 1). There
was no significant interaction between injection and hous-
ing in determining maternal hepatic activity of G6Pase or
PEPCK (Fig. 1B & C, Table 1). Maternal hepatic activity
of G6Pase, but not PEPCK, was positively correlated with
maternal plasma corticosterone concentration, irrespective
of whether activity was expressed per gram protein
(G6Pase, r = 0.686, P < 0.01, n = 24; PEPCK, r = 0.443,
P > 0.05, n = 23) or per gram wet weight of liver
(G6Pase, r = 0.614, P < 0.01, n = 24; PEPCK, r = 0.401,
P > 0.05, n = 23). There were no correlations between
maternal blood glucose concentrations and hepatic activi-
ties of G6Pase or PEPCK (P > 0.05, all cases).
Like the dams, fetal hepatic G6Pase expressed either
per gram protein or per gram wet weight of liver was
higher in saline-injected than uninjected groups and was
unaffected by housing (Fig. 2B, Table 2). In contrast, fetal
hepatic PEPCK activity per gram protein or per gram wet
weight of liver was affected significantly by injection in a
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manner that depended on housing (Fig. 2C, Table 2). In
injected groups, fetal hepatic PEPCK activity was higher
in singly than pair-housed dams, whereas, the reverse was
seen in uninjected groups (Fig. 2C, Table 2). There were
no correlations between fetal blood glucose concentra-
tions and activity of either enzyme however values were
expressed (P > 0.05, all cases).
Discussion
The results demonstrate that both single housing and sal-
ine injection of pregnant rats alter the hepatic glucogenic
capacity of maternal and fetal liver near term. There were
also interactions between housing and injection in deter-
mining hepatic activities of G6Pase and PEPCK. These
changes were accompanied by alterations in feto-placental
growth, which may have contributed to the fetal hepatic
phenotype. Compared to uninjected pair-housed dams,
single housing and saline injection both reduced placental
growth. However, fetal weight was reduced significantly
only in the injected dams and not in the single-housed
uninjected dams that also had reduced placental weight.
The changes in hepatic glucogenic capacity were also
accompanied by reduced food intake in late gestation
during single housing and by increased corticosterone
concentrations in saline-injected dams. These findings
indicate that, single housing and saline injection are both
stressors in pregnant rats, which alter growth and hepatic
metabolism of the mother and her fetuses with potential
consequences for their glucose metabolism after birth.
In maternal liver, saline injection reduced glycogen
content and increased G6Pase activity, irrespective of
housing conditions. Given the short time frame between
anesthesia and tissue collection and the finding that
maternal glucose concentrations immediately after anes-
thesia were unaffected by daily injection, the low hepatic
glycogen levels of the saline-injected dams are unlikely to
be due to hepatic glycogenolysis during the acute terminal
procedures. They are more likely to reflect accumulated
effects of enhanced glycogenolysis and/or decreased glyco-
gen synthesis in response to the daily stress of handling
and saline injection over the preceding 5 days, particu-
larly as corticosterone concentrations were raised in these
dams. These higher corticosterone concentrations may
also explain the elevated hepatic G6Pase activity of
injected dams as glucocorticoids stimulate hepatic G6Pase
activity in nonpregnant rats (Weber and Cantero 1957).
Certainly, there was a significant positive correlation
between corticosterone concentrations and hepatic G6Pase
activity in the pregnant dams used here. In contrast,
maternal hepatic PEPCK activity was unaffected by
injection but was two- to threefold higher in singly than
Table 1. The effect of stress during pregnancy on maternal characteristics.
Pair housed Single housed Significance
Uninjected Injected Uninjected Injected Housing Injection Interaction
Body weight g
Day 0 277  14 286  9 271  16 266  15 NS NS NS
Day 20 428  20 405  23 398  18 366  22 0.011 NS NS
Gain 0–20 150  13 125  8 128  11 100  17 0.034 0.019 NS
Food intake g/day/rat
0–10 days 23.8  0.8 23.3  1.3 21.5  0.8 21.1  0.7 NS NS NS
11–15 days 26.4  2.0 27.8  2.2 24.8  1.6 23.5  1.2 NS NS NS
16–20 days 30.7  1.9 30.8  2.6 25.6  1.0 24.4  1.6 0.007 NS NS
Litter size 14.4  1.0 14.6  0.8 14.3  0.8 14.0  0.6 NS NS NS
Corticosterone ng/mL 571  53 691  55 565  94 818  51 NS 0.016 NS
Glucose mmol/L 4.18  0.25 5.93  0.88 4.90  0.63 5.38  1.27 NS NS NS
Liver
Protein content mg/g 162.1  5.5 171.6  5.2 168.4  12.5 145.3  5.9*† NS NS 0.028
G6Pase U/g wet wt 6.01  0.51 9.71  1.07 6.28  1.32 9.22  0.38 NS 0.001 NS
PEPCK U/g wet wt 0.96  0.18 1.02  0.17 2.72  0.43 2.63  0.37 <0.001 NS NS
Mean (SEM) values of body weight, weight gain, food intake, litter size, concentrations of plasma corticosterone and blood glucose and of
hepatic protein content, and activities of glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) per gram liver at
day (D) 20 of pregnancy in rats that were pair or single housed from conception and either uninjected or injected with saline from D15 to
D19. Pair housed: untreated n = 8, saline injected n = 7 for dams and untreated n = 4, saline injected n = 3 for cages for food intake; Single
housed: untreated n = 6, saline injected n = 7 for dams and cages. Statistical significance was assessed by two-way ANOVA with Holm–Sidak
post hoc test. NS = Not significant. Significant P values for effects are shown in bold.
*Interactions: Significantly different from the value in the uninjected group in the same housing conditions (P < 0.01).
†Interactions: Significantly different from the value in saline-injected pair housed groups (P < 0.01).
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pair-housed groups. These changes may reflect maternal
nutritional state as food intake was lower in singly housed
dams during late gestation. Previous studies in nonpreg-
nant rats have shown that reducing dietary carbohydrate
intake increases hepatic PEPCK activity (Perez et al. 1964;
Lanoue et al. 1999). Collectively, the current findings
indicate that both corticosterone and lower nutrient
intake are important influences on maternal glucogenic
capacity during rat pregnancy, but that they act differen-
tially on the two enzymes studied with hepatic G6Pase,
the final rate-limiting enzyme of both glycogenolysis and
gluconeogenesis, more sensitive to glucocorticoids and
PEPCK, the rate-limiting enzyme specifically of gluconeo-
genesis, more responsive to undernutrition. This is con-
sistent with the known roles of glycogenolysis as an
immediate source of extra glucose during stress and glu-
coneogenesis as a longer-term source of glucose for essen-
tial processes when its dietary availability is restricted
(Perez et al. 1964).
Single housing and injection of the dams also impaired
feto-placental growth in line with the reduced maternal
weight gain during pregnancy in these groups. Again,
these effects on conceptus growth were probably related
to the reduced maternal food intake and raised corticos-
terone concentrations. Both these factors are known to
reduce placental and fetal weight in rats (Nyirenda et al.
1998; Ain et al. 2005; Belkacemi et al. 2012). Recent stud-
ies in pregnant mice have also shown that, while maternal
undernutrition and corticosterone administration produce
a similar reduction in placental weight, their effects on
placental nutrient transfer capacity differ (Coan et al.
2010; Vaughan et al. 2012). Corticosterone administration
reduced placental amino acid transport, whereas under-
nutrition increased amino acid transfer across the small
placenta, which helped to sustain fetal growth in the
undernourished animals (Coan et al. 2010; Vaughan et al.
2012). These observations are consistent with the current
findings that fetal weight was only influenced by injection
with no interaction with housing. Thus, fetal growth may
have been maintained in uninjected single-housed dams
with reduced food intake by upregulating amino acid
transfer across their small placenta. However, the alter-
ations in fetal growth may not be due solely to placental
changes. The raised maternal corticosterone concentra-
tions may also have a more direct inhibitory effect on
fetal growth as transplacental corticosterone transfer
Table 2. The effects of stress during pregnancy on fetal characteristics.
Pair housed Single housed Significance
Uninjected Injected Uninjected Injected Housing Injection Interaction
Placental weight mg 733  37 578  25* 606  47† 584  11 NS 0.008 0.038
Body weight (BW) g 4.04  0.18 3.48  0.07 3.77  0.08 3.60  0.07 NS 0.007 NS
Liver weight
mg 346  15 290  9 280  13 276  11 0.017 NS NS
% BW 8.5  0.2 8.3  0.2 7.5  0.2 7.7  0.4 0.002 NS NS
Liver protein content mg/g 101.8  3.5 96.5  6.7 112.9  4.5 103.1  2.2 NS NS NS
Liver Glycogen
Total mg 30.4  4.8 11.2  1.2* 13.6  1.4† 14.7  2.0 0.033 0.005 <0.001
mg/g fetus 6.9  0.7 3.2  0.3* 3.7  0.3† 4.1  0.5 0.036 0.007 0.001
Liver G6Pase
Total mU 408  37 476  103 389  65 528  35 NS NS NS
U/g liver 1.24  0.10 1.55  0.15 1.40  0.25 1.89  0.10 NS 0.012 NS
mU/g fetus 107  8 136  26 104  18 146  9 NS 0.032 NS
Liver PEPCK
Total mU 95  8 89  15 51  7† 124  11*† NS 0.006 0.002
U/g liver 0.30  0.02 0.24  0.04 0.18  0.02† 0.46  0.03*† NS 0.003 <0.001
mU/g fetus 25  2 25  5 14  2† 34  3*† NS 0.001 0.002
Glucose mmol/L 4.23  0.61 3.78  0.37 4.55  0.18 4.20  0.49 NS NS NS
Mean (SEM) values of placental, fetal body and liver weights, blood glucose concentrations, and of hepatic glycogen content and activities
of glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) expressed on an absolute and weight-specific basis in rat
fetuses at day 20 of gestation from dams that were pair or single housed from conception and either uninjected or injected with saline from
days 15 to 19 of pregnancy. Pair housed: untreated n = 6–8 litters, saline injected n = 6–7 litters; Single housed: untreated n = 5–6 litters, sal-
ine injected n = 7 litters. Statistical significance was assessed by two-way ANOVA with Holm–Sidak post hoc test. NS = Not significant. Signifi-
cant P values of effects are shown in bold.
*Interactions: Significantly different from the value in the uninjected group in the same housing conditions (P < 0.01).
†Interactions: Significantly different from the value in the corresponding injected or uninjected pair housed group (P < 0.01).
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
2017 | Vol. 5 | Iss. 11 | e13293
Page 5
K. L. Franko et al. Pregnancy Stress and Glucogenic Capacity
occurs in pregnant rats during restraint stress and pro-
longed dietary restriction (Ward and Weisz 1984; Lesage
et al. 2001; Straud et al. 2006; Belkacemi et al. 2012).
Whatever the cause, impaired placental growth and func-
tion would decrease total substrate availability for fetal
growth and deposition of fuel reserves, such as glycogen
(Oh et al. 1970). Indeed, in this study, fetal hepatic glyco-
gen content was low in all groups with reduced placental
weight.
Fetal hepatic G6Pase mirrored maternal values with
higher activities in saline-injected groups irrespective of
housing. In contrast, fetal hepatic PEPCK activity differed
in profile from the maternal activities with injection inter-
acting with housing in the fetuses. This suggests that,
unlike the dams, both an impaired nutrient supply and
increased corticosterone exposure are required to increase
hepatic PEPCK activity in the fetus, a scenario which
Figure 1. Mean (SEM) maternal hepatic glycogen content (A)
and activity of glucose-6-phosphatase (G6Pase, B) and
phosphoenolpyruvate carboxykinase (PEPCK, C) at day (D) 20 of
pregnancy with the statistical significance of the effects of housing,
injection, and their interaction in rats housed singly or in pairs
either uninjected (UI) or injected with saline (INJ) from D15 to D19
by two-way ANOVA. NS = Not significant. (Pair housed: uninjected
n = 8 dams, saline injected n = 7 dams; Singly housed: uninjected
n = 6 dams, saline injected n = 7 dams).
Figure 2. Mean (SEM) fetal hepatic glycogen content (A) and
activities of glucose-6-phosphatase (G6Pase, B) and
phosphoenolpyruvate carboxykinase (PEPCK, C) activity at day (D)
20 of gestation with the statistical significance of the effects of
housing, injection, and their interaction in rats housed singly or in
pairs either uninjected (UI) or injected with saline (INJ) from D15 to
D19 by two-way ANOVA with Holm–Sidak post hoc test where *=
P < 0.01 between-individual groups when there was a significant
interaction. NS = Not significant. (Pair-housed: uninjected n = 7–8
litters, saline injected n = 6–7 litters; Singly housed: uninjected
n = 5–6 litters, saline injected n = 7 litters).
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would preserve amino acids for fetal tissue accretion for
as long as possible. Nutrition and glucocorticoids are
known to regulate fetal glucogenic capacity in species
more mature than rodents at birth (Fowden et al. 1998).
In fetal sheep and pigs, hepatic G6Pase activity and glyco-
gen deposition are glucocorticoid dependent and are
increased by fetal and maternal glucocorticoid treatment
in late gestation (Fowden et al. 1993, 1995; Franko et al.
2010). Fetal hepatic PEPCK activity is also increased by
cortisol overexposure in these species, although it appears
to be less glucocorticoid sensitive than G6Pase activity
(Fowden et al. 1993; Franko et al. 2010). Hepatic PEPCK
gene expression is also increased in term rat pups by
preimplantation dietary protein deprivation (Kwong et al.
2007). Collectively, the current findings suggest that fetal
hepatic G6Pase and PEPCK activities may have similar
nutritional and glucocorticoid sensitivities in rats as seen
in other species, as the highest activities were seen in
fetuses exposed to lower maternal food intake and greater
maternal corticosterone concentrations. Indeed, upregula-
tion of these hepatic enzyme activities in fetuses of the
singly housed, saline-injected rat dams more than com-
pensated for the reduced fetal liver weight as enzyme
activity per gram fetus was highest in this group. This
may also offset, in part, the limited glycogen availability
for hepatic glucogenesis. If these adaptations persist after
birth, they may have consequences for postnatal glucose
metabolism similar to those seen in adult rats which were
growth retarded in utero by more severe nutritional and
glucocorticoid treatments (Desai et al. 1997; Nyirenda
et al. 1998; Gallo et al. 2012).
In summary, the current findings show that the experi-
mental procedures commonly used as controls in study-
ing developmental programming are stressful and will
themselves alter fetal hepatic development. Most rodent
studies of developmental programming are, therefore,
examining the effects of adverse environmental superim-
posed upon unnatural conditions created by the experi-
mental procedures per se. This combination of pregnancy
stresses may result in a different metabolic phenotype
than either stress alone and explain, in part, the variations
in offspring outcomes seen after apparently similar mater-
nal dietary or other manipulations during pregnancy
(McMillen and Robinson 2005; Mina and Reynolds
2014). For example, in this study, the effect of maternal
saline injection on the hepatic glucogenic capacity of the
fetuses depended on the housing conditions. This study
also demonstrates that developmental programming by
suboptimal conditions may occur directly via changes in
the fetus or indirectly through altered maternal metabo-
lism or placental development. It also emphasizes sensitiv-
ity of hepatic development to environmental cues
unnatural in an evolutionary context in rodents and
highlights the potential role of experimental procedures
per se in modifying the phenotypical outcome of environ-
mental challenges during pregnancy.
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